These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 31943160)

  • 21. TGFBR2 mutation is correlated with CpG island methylator phenotype in microsatellite instability-high colorectal cancer.
    Ogino S; Kawasaki T; Ogawa A; Kirkner GJ; Loda M; Fuchs CS
    Hum Pathol; 2007 Apr; 38(4):614-20. PubMed ID: 17270239
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Possible role of Cdx2 in the serrated pathway of colorectal cancer characterized by BRAF mutation, high-level CpG Island methylator phenotype and mismatch repair-deficiency.
    Dawson H; Galván JA; Helbling M; Muller DE; Karamitopoulou E; Koelzer VH; Economou M; Hammer C; Lugli A; Zlobec I
    Int J Cancer; 2014 May; 134(10):2342-51. PubMed ID: 24166180
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comprehensive analysis of CpG island methylator phenotype (CIMP)-high, -low, and -negative colorectal cancers based on protein marker expression and molecular features.
    Zlobec I; Bihl M; Foerster A; Rufle A; Lugli A
    J Pathol; 2011 Nov; 225(3):336-43. PubMed ID: 21660972
    [TBL] [Abstract][Full Text] [Related]  

  • 24. BRAF mutation is associated with DNA methylation in serrated polyps and cancers of the colorectum.
    Kambara T; Simms LA; Whitehall VL; Spring KJ; Wynter CV; Walsh MD; Barker MA; Arnold S; McGivern A; Matsubara N; Tanaka N; Higuchi T; Young J; Jass JR; Leggett BA
    Gut; 2004 Aug; 53(8):1137-44. PubMed ID: 15247181
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Smoking, alcohol consumption and colorectal cancer risk by molecular pathological subtypes and pathways.
    Amitay EL; Carr PR; Jansen L; Roth W; Alwers E; Herpel E; Kloor M; Bläker H; Chang-Claude J; Brenner H; Hoffmeister M
    Br J Cancer; 2020 May; 122(11):1604-1610. PubMed ID: 32225169
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Body mass index and molecular subtypes of colorectal cancer.
    Murphy N; Newton CC; Song M; Papadimitriou N; Hoffmeister M; Phipps AI; Harrison TA; Newcomb PA; Aglago EK; Berndt SI; Brenner H; Buchanan DD; Cao Y; Chan AT; Chen X; Cheng I; Chang-Claude J; Dimou N; Drew D; Farris AB; French AJ; Gallinger S; Georgeson P; Giannakis M; Giles GG; Gruber SB; Harlid S; Hsu L; Huang WY; Jenkins MA; Laskar RS; Le Marchand L; Limburg P; Lin Y; Mandic M; Nowak JA; Obón-Santacana M; Ogino S; Qu C; Sakoda LC; Schoen RE; Southey MC; Stadler ZK; Steinfelder RS; Sun W; Thibodeau SN; Toland AE; Trinh QM; Tsilidis KK; Ugai T; Van Guelpen B; Wang X; Woods MO; Zaidi SH; Gunter MJ; Peters U; Campbell PT
    J Natl Cancer Inst; 2023 Feb; 115(2):165-173. PubMed ID: 36445035
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Annexin A10 expression correlates with serrated pathway features in colorectal carcinoma with microsatellite instability.
    Kim JH; Rhee YY; Kim KJ; Cho NY; Lee HS; Kang GH
    APMIS; 2014 Dec; 122(12):1187-95. PubMed ID: 24909058
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intake of Dietary Fruit, Vegetables, and Fiber and Risk of Colorectal Cancer According to Molecular Subtypes: A Pooled Analysis of 9 Studies.
    Hidaka A; Harrison TA; Cao Y; Sakoda LC; Barfield R; Giannakis M; Song M; Phipps AI; Figueiredo JC; Zaidi SH; Toland AE; Amitay EL; Berndt SI; Borozan I; Chan AT; Gallinger S; Gunter MJ; Guinter MA; Harlid S; Hampel H; Jenkins MA; Lin Y; Moreno V; Newcomb PA; Nishihara R; Ogino S; Obón-Santacana M; Parfrey PS; Potter JD; Slattery ML; Steinfelder RS; Um CY; Wang X; Woods MO; Van Guelpen B; Thibodeau SN; Hoffmeister M; Sun W; Hsu L; Buchanan DD; Campbell PT; Peters U
    Cancer Res; 2020 Oct; 80(20):4578-4590. PubMed ID: 32816852
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Alcohol intake and colorectal cancer risk by molecularly defined subtypes in a prospective study of older women.
    Razzak AA; Oxentenko AS; Vierkant RA; Tillmans LS; Wang AH; Weisenberger DJ; Laird PW; Lynch CF; Anderson KE; French AJ; Haile RW; Harnack LJ; Slager SL; Smyrk TC; Thibodeau SN; Cerhan JR; Limburg PJ
    Cancer Prev Res (Phila); 2011 Dec; 4(12):2035-43. PubMed ID: 21900595
    [TBL] [Abstract][Full Text] [Related]  

  • 30. External validation of molecular subtype classifications of colorectal cancer based on microsatellite instability, CIMP, BRAF and KRAS.
    Alwers E; Bläker H; Walter V; Jansen L; Kloor M; Arnold A; Sieber-Frank J; Herpel E; Tagscherer KE; Roth W; Chang-Claude J; Brenner H; Hoffmeister M
    BMC Cancer; 2019 Jul; 19(1):681. PubMed ID: 31296182
    [TBL] [Abstract][Full Text] [Related]  

  • 31. BRAF mutation, CpG island methylator phenotype and microsatellite instability occur more frequently and concordantly in mucinous than non-mucinous colorectal cancer.
    Tanaka H; Deng G; Matsuzaki K; Kakar S; Kim GE; Miura S; Sleisenger MH; Kim YS
    Int J Cancer; 2006 Jun; 118(11):2765-71. PubMed ID: 16381005
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A Prospective Study of Smoking and Risk of Synchronous Colorectal Cancers.
    Drew DA; Nishihara R; Lochhead P; Kuchiba A; Qian ZR; Mima K; Nosho K; Wu K; Wang M; Giovannucci E; Fuchs CS; Chan AT; Ogino S
    Am J Gastroenterol; 2017 Mar; 112(3):493-501. PubMed ID: 28117362
    [TBL] [Abstract][Full Text] [Related]  

  • 33. MicroRNA-31 expression in relation to BRAF mutation, CpG island methylation and colorectal continuum in serrated lesions.
    Ito M; Mitsuhashi K; Igarashi H; Nosho K; Naito T; Yoshii S; Takahashi H; Fujita M; Sukawa Y; Yamamoto E; Takahashi T; Adachi Y; Nojima M; Sasaki Y; Tokino T; Baba Y; Maruyama R; Suzuki H; Imai K; Yamamoto H; Shinomura Y
    Int J Cancer; 2014 Dec; 135(11):2507-15. PubMed ID: 24752710
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Genetic and epigenetic classifications define clinical phenotypes and determine patient outcomes in colorectal cancer.
    Sanchez JA; Krumroy L; Plummer S; Aung P; Merkulova A; Skacel M; DeJulius KL; Manilich E; Church JM; Casey G; Kalady MF
    Br J Surg; 2009 Oct; 96(10):1196-204. PubMed ID: 19787768
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The impact of CpG island methylator phenotype and microsatellite instability on tumour budding in colorectal cancer.
    Zlobec I; Bihl MP; Foerster A; Rufle A; Lugli A
    Histopathology; 2012 Nov; 61(5):777-87. PubMed ID: 22803799
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Metabolic factors and the risk of colorectal cancer by KRAS and BRAF mutation status.
    Myte R; Gylling B; Häggström J; Häggström C; Zingmark C; Löfgren Burström A; Palmqvist R; Van Guelpen B
    Int J Cancer; 2019 Jul; 145(2):327-337. PubMed ID: 30613980
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fatty acid synthase overexpression in colorectal cancer is associated with microsatellite instability, independent of CpG island methylator phenotype.
    Ogino S; Kawasaki T; Ogawa A; Kirkner GJ; Loda M; Fuchs CS
    Hum Pathol; 2007 Jun; 38(6):842-9. PubMed ID: 17350669
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Associations of red and processed meat intake with major molecular pathological features of colorectal cancer.
    Carr PR; Jansen L; Bienert S; Roth W; Herpel E; Kloor M; Bläker H; Chang-Claude J; Brenner H; Hoffmeister M
    Eur J Epidemiol; 2017 May; 32(5):409-418. PubMed ID: 28646407
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dietary intake of fiber, whole grains and risk of colorectal cancer: An updated analysis according to food sources, tumor location and molecular subtypes in two large US cohorts.
    He X; Wu K; Zhang X; Nishihara R; Cao Y; Fuchs CS; Giovannucci EL; Ogino S; Chan AT; Song M
    Int J Cancer; 2019 Dec; 145(11):3040-3051. PubMed ID: 31044426
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Calcium intake and colon cancer risk subtypes by tumor molecular characteristics.
    Keum N; Liu L; Hamada T; Qian ZR; Nowak JA; Cao Y; da Silva A; Kosumi K; Song M; Nevo D; Wang M; Chan AT; Meyerhardt JA; Fuchs CS; Wu K; Ogino S; Nishihara R; Zhang X
    Cancer Causes Control; 2019 Jun; 30(6):637-649. PubMed ID: 30963391
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.